ask our doctors

Cutaneous T Cell Lymphoma

Get the facts on Cutaneous T Cell Lymphoma treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Cutaneous T Cell Lymphoma prevention, screening, research, statistics and other Cutaneous T Cell Lymphoma related topics. We answer all your qestions about Cutaneous T Cell Lymphoma.

Question: my friend has cancer, can you answer a question i have? He is a 17 year old Caucasian Male. He has Mycosis fungoides which is the most common form of cutaneous T-cell lymphoma. It was not caught until it had advanced into a more serious stage. He was in remission for a while, but its back and i was wondering if he had a good chance of being just fine?

Answer: From… "Prognosis Mycosis fungoides and Sézary syndrome are incurable conditions in most patients, with the exception of those with stage IA disease. Mortality and prognosis are related to the stage at diagnosis Patients diagnosed with stage IA disease (patch or plaque skin disease limited to <10% of the skin surface area) who undergo treatment, have an overall life expectancy similar to the age-, sex-, and race-matched controls. Patients who have stage IIB disease with cutaneous tumors have a median survival rate of 3.2 years, and those who have stage III disease (generalized erythroderma) have a median survival rate of 4-6 years. Patients with extracutaneous disease stage IVA (lymph nodes) or stage IVB (viscera) have a survival rate of less than 1.5 years.

Cutaneous T Cell Lymphoma News